日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Pilot Feasibility Study of a Group-Based Remote-Delivered Dyadic Exercise Intervention in Hispanic Men With Prostate Cancer and Their Caregivers

一项针对患有前列腺癌的西班牙裔男性及其照护者的基于小组的远程双人运动干预的试点可行性研究

Skiba, Meghan B; Contreras, Juan 2nd; Nelson, Marjorie A; Recio-Boiles, Alejandro; Garcia, David O; Chilton, Floyd H; Segrin, Chris; Badger, Terry A; Winters-Stone, Kerri M

Applying Virtual Community Engagement Studio to Inform a Dyadic Text Message Intervention for Diet, Physical Activity, and Sleep After Cancer

运用虚拟社区参与工作室为癌症术后饮食、运动和睡眠的双人短信干预提供信息

Skiba, Meghan B; Nelson, Marjorie A; Badger, Terry A; Chriswell, Amanda; Recio-Boiles, Alejandro; Segrin, Chris; Fox, Rina S

Inhibition of PIM Kinase in Tumor-Associated Macrophages Suppresses Inflammasome Activation and Sensitizes Prostate Cancer to Immunotherapy

抑制肿瘤相关巨噬细胞中的PIM激酶可抑制炎症小体激活并增强前列腺癌对免疫疗法的敏感性

Amber N Clements ,Andrea L Casillas ,Caitlyn E Flores ,Hope Liou ,Rachel K Toth ,Shailender S Chauhan ,Kai Sutterby ,Sachin Kumar Deshmukh ,Sharon Wu ,Joanne Xiu ,Alex Farrell ,Milan Radovich ,Chadi Nabhan ,Elisabeth I Heath ,Rana R McKay ,Noor Subah ,Sara Centuori ,Travis J Weeler ,Anne E Cress ,Gregory C Rogers ,Justin E Wilson ,Alejandro Recio-Boiles ,Noel A Warfel

Azenosertib Is a Potent and Selective WEE1 Kinase Inhibitor with Broad Antitumor Activity Across a Range of Solid Tumors

Azenosertib 是一种强效且选择性的 WEE1 激酶抑制剂,对多种实体瘤具有广泛的抗肿瘤活性。

Jianhui Ma # ,Wen Liu # ,Jiali Li # ,Daehwan Kim ,Sangyub Kim ,Alexandra Levy ,Zhen Cai ,Kevin D Bunker ,Alejandro Recio-Boiles ,Jennifer M Segar ,Shiraj Sen ,Deborah B Doroshow ,Danielle Jandial ,Michael Rutgard ,Olivier Harismendy ,Stephan K Grant ,Ahmed A Samatar ,Kimberlee M Fischer ,Mark R Lackner

Case Report: Novel molecular characterization of rare primary mucinous adenocarcinoma of the renal pelvis

病例报告:肾盂罕见原发性黏液腺癌的新型分子特征

Taylor, Megan K; Paster, Irasema C; Arevelo Salazar, Dory E; Chipollini, Juan; Recio Boiles, Alejandro

Corticosteroid-Refractory Bullous Pemphigoid Due to Immune Checkpoint Inhibitors: A Telemedicine Challenge

免疫检查点抑制剂引起的皮质类固醇难治性大疱性类天疱疮:远程医疗的挑战

Marco, Tom; Bertolo, Aaron; Srivastava, Rishab; Barker, Kenneth; Recio Boiles, Alejandro

Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3

Sacituzumab Govitecan 联合 Pembrolizumab 治疗铂类化疗后进展的转移性尿路上皮癌患者:TROPHY-U-01 队列 3

Grivas, Petros; Pouessel, Damien; Park, Chandler H; Barthelemy, Philippe; Bupathi, Manojkumar; Petrylak, Daniel P; Agarwal, Neeraj; Gupta, Sumati; Fléchon, Aude; Ramamurthy, Chethan; Davis, Nancy B; Recio-Boiles, Alejandro; Sternberg, Cora N; Bhatia, Astha; Pichardo, Cabilia; Sierecki, Mitch; Tonelli, Julia; Zhou, Huafeng; Tagawa, Scott T; Loriot, Yohann

Inhibition of PIM kinase in tumor associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapy

抑制肿瘤相关巨噬细胞中的PIM激酶可抑制炎症小体活化,并使前列腺癌对免疫疗法更加敏感。

Clements, Amber N; Casillas, Andrea L; Flores, Caitlyn E; Liou, Hope; Toth, Rachel K; Chauhan, Shailender S; Sutterby, Kai; Deshmukh, Sachin Kumar; Wu, Sharon; Xiu, Joanne; Farrell, Alex; Radovich, Milan; Nabhan, Chadi; Heath, Elisabeth I; McKay, Rana R; Subah, Noor; Centuori, Sara; Wheeler, Travis J; Cress, Anne E; Rogers, Gregory C; Wilson, Justin E; Recio-Boiles, Alejandro; Warfel, Noel A

Current Landscape of Immune Checkpoint Inhibitors for Metastatic Urothelial Carcinoma: Is There a Role for Additional T-Cell Blockade?

转移性尿路上皮癌免疫检查点抑制剂的现状:是否需要额外的 T 细胞阻断疗法?

Ogbuji, Vanessa; Paster, Irasema C; Recio-Boiles, Alejandro; Carew, Jennifer S; Nawrocki, Steffan T; Chipollini, Juan

Health Disparities in Presentation, Treatment, Genomic Testing, and Outcomes of Pancreatic Cancer in Hispanic and Non-Hispanic Patients

西班牙裔和非西班牙裔胰腺癌患者在就诊、治疗、基因组检测和预后方面的健康差异

Halder, Ritika; Veeravelli, Sumana; Cheng, Ce; Estrada-Mendizabal, Ricardo J; Recio-Boiles, Alejandro